This may result in reduced functionality and affect the graphical presentation of this site.
However, all content will still be available.
The first ever dual-construct HVT vaccine to protect against Infectious Bursal Disease, Newcastle Disease and Marek’s Disease in a single, non-reactive vaccine.
Studies on the viability of an <span>rHVT</span>
WVPA 2017 - Clinical Case Reports and Key Studies
2016 AAAP Abstract_Ivan Alvarado